Logo

NIH contract

Domus Diagnostics Wins $2.4M NIH RADx Tech Contract

The firm will use the funding to validate a rapid, low-cost, zero-power multiplex assay for COVID-19, flu A and B, and respiratory syncytial virus.

Immy Wins $1.5M NIH Contract for Point-of-Care Talaromycosis Test

Talaromycosis is an infection caused by airborne inhalation of the fungus Talaromyces marneffei and is endemic in Southeast Asia.

RADx Issues $77.7M in New Contracts for SARS-CoV-2 Rapid Diagnostic Tests

The awards support the development, validation, scale-up, and manufacturing of the tests with the goal of bringing them to market as early as this year.

NIH Awards Qorvo Biotechnologies $24.4M for Rapid SARS-CoV-2 Antigen Test

The firm said that its point-of-care antigen testing platform uses high-frequency bulk acoustic wave sensors to detect SARS-CoV-2 at low limits of detection.

RAD-X Awards Six Phase 2 Contracts for COVID-19 Testing

The awards will support clinical validation, manufacturing, and scale up for SARS-CoV-2 viral antigen and molecular detection.